FreeOx Biotech, a CataloniaBio & HealthTech member, has been granted a patent for its most advanced drug, Ox-01, by the United States Patent and Trademark Office (USPTO). The patent protects the use o...
Read moreHaving a solid scientific project and the right patent to protect it are key to raise funding in health innovation projects, according to the three entrepreneurs that participated in the 3rd webinar o...
Read moreTo bring your biologic to market as quickly as possible, streamlined scale up is essential. By combining standardized, single-use platform technologies that can be customized to your particular proces...
Read moreVETGENOMICS, SL company, an international leader in diagnosis and research in "One Health" with expertise in genomics, pathogens and microbiome has obtained the American grant of the patent "METHODS F...
Read moreThe Vall d’Hebron Research Institute (VHIR) obtained more than €1 million in profit from the use of a patent of a new treatment for a mitochondrial rare disease caused by TK2 deficiency. It is ...
Read moreModesto Orozco’s lab has published a paper in Chemical Communications about a therapeutic tool to prevent treatment resistance in breast cancer. The tool has been tested in tumour cells in vitro and...
Read moreThe patent is a method to integrate data from mass spectrometry which greatly increases the performance in identifying peptides and proteins.
Read moreThe supplement, which originated in the University of the Balearic Islands Laboratory of Renal Lithiasis Research, has been proven effective in both in vitro and in vivo models, as well as three epide...
Read moreThe designed compounds have particularly high therapeutic effects on tumour cells of breast and colon and can be the basis for the development of oncological drugs of low toxicity and high selectivity...
Read more